Chronic Opioid Therapy and Sleep: An American Academy of Sleep Medicine Position Statement. Article

Rosen, Ilene M, Aurora, R Nisha, Kirsch, Douglas B et al. (2019). Chronic Opioid Therapy and Sleep: An American Academy of Sleep Medicine Position Statement. . 15(11), 1671-1673. 10.5664/jcsm.8062

cited authors

  • Rosen, Ilene M; Aurora, R Nisha; Kirsch, Douglas B; Carden, Kelly A; Malhotra, Raman K; Ramar, Kannan; Abbasi-Feinberg, Fariha; Kristo, David A; Martin, Jennifer L; Olson, Eric J; Rosen, Carol L; Rowley, James A; Shelgikar, Anita V; American Academy of Sleep Medicine Board of Directors

authors

abstract

  • None

    There is a complex relationship among opioids, sleep and daytime function. Patients and medical providers should be aware that chronic opioid therapy can alter sleep architecture and sleep quality as well as contribute to daytime sleepiness. It is also important for medical providers to be cognizant of other adverse effects of chronic opioid use including the impact on respiratory function during sleep. Opioids are associated with several types of sleep-disordered breathing, including sleep-related hypoventilation, central sleep apnea (CSA), and obstructive sleep apnea (OSA). Appropriate screening, diagnostic testing, and treatment of opioid-associated sleep-disordered breathing can improve patients' health and quality of life. Collaboration among medical providers is encouraged to provide high quality, patient-centered care for people who are treated with chronic opioid therapy.

publication date

  • November 1, 2019

keywords

  • American Academy of Sleep Medicine Board of Directors
  • Analgesics, Opioid
  • Humans
  • Practice Guidelines as Topic
  • Sleep
  • Sleep Apnea Syndromes
  • Sleep Medicine Specialty

Digital Object Identifier (DOI)

Medium

  • Print

start page

  • 1671

end page

  • 1673

volume

  • 15

issue

  • 11